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.,‘rbstract In Xenopus prophase-blocked oocytes, it is assumed 
that progesterone interacts with the plasma membrane to initiate 
a signalling cascade that ultimately leads to MPF activation. 
Progesterone regulates negatively the CAMP pathway through an 
inhibition of adenylate cyclase. However, the mechanisms linking 
the initial action of the hormone with adenylate cyclase activity 
remain to be elucidated. Here, we demonstrate that PDMP, an 
inhibitor of glucosphingolipid synthesis, triggers oocyte meiotic 
maturation in a CAMP- and cycloheximide-dependent manner, 
whereas exogenous ceramide is unefficient. We propose that 
sphingolipid metabolism and targeting represent an important 
regulatory process of oocyte meiosis. 
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1. Introduction 
Sphingolipids were recently identified as potential second 
inessengers in the regulation of cell proliferation, cell division, 
( s well as mediators of cell death [l-4]. Varnold and Smith [5,6] 
‘eported that sphingomyelinase (SMase) from Staphylococcus 
.~ureus is a potent inducer of germinal vesicle breakdown 
1 GVBD) in full-grown prophase-blocked oocytes of Xenopus. 
‘his result suggests a role for the sphingomyelin pathway (Fig. 
) in Xenopus oocytes in the activation of M-phase promoting 
~ actor (MPF), a complex between the ~34~‘~ kinase and cyclin 
13 responsible for entry into M-phase of the eukaryotic cell cycle 
71. Very recently, while this work was under progress, Strum 
..t al [8] confirmed that exogenous SMase induces activation of 
/134CdC2 and GVBD in Xenopus oocytes, in the absence of the 
:lhysiological inducer progesterone. Since exogenous SMase 
vould be expected to catalyze the hydrolysis of membrane 
\~phingomyelin into ceramide and phosphocholine [9], it may be 
assumed that a transient increase in ceramide or in ceramide 
netabolites stimulates a signalling pathway leading to the acti- 
ration of MPF. The effect of exogenous SMase raises impor- 
ant questions, among them: are sphingolipids involved in the 
>oorly understood initial action of progesterone, the natural 
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inducer of MPF and meiotic maturation [lo]? Which cellular 
targets are stimulated by sphingolipids and how are they con- 
nected with the ~34”~“’ activating pathway? 
In a first approach to answer these questions, we investigated 
the effects of different agents that interfer with the metabolism 
of sphingolipids. After having confirmed that addition of vari- 
ous SMases to oocyte culture medium induces maturation, we 
now report that m-threo-l-phenyl-2-decanoylamino-3-mor- 
pholino- 1 -propanol (PDMP), an inhibitor of glucosylceramide 
synthase [l l] (Fig. l), an enzyme localized in the pre-Golgi/ 
Golgi apparatus, induces in a dose-dependent manner an ap- 
parent normal meiotic maturation. Interestingly, at low doses 
inefficient to cause GVBD, PDMP potentializes progesterone- 
induced maturation. 
These data strengthen the importance of the sphingomyehn 
pathway in the mechanism of oocyte maturation. They also 
indicate that the metabolism of sphingolipids is highly regu- 
lated in the Xenopus prophase-arrested oocyte. 
2. Materials and methods 
2.1. Materials 
Xenopus laevis adult females (Centre de Recherche de Biochimie 
Macromoleculaire, CNRS, Montpellier, France) were bred and main- 
tained under laboratory conditions. Sphyngomyehnases (SMases) from 
Staphylococcus aureus and from Streptomvces sp. are references 8633 
and 8889 from Sigma, respectively. m-Threo-1-phenyl-2-decanoylam- 
ino-3-morpholino-1-propanol (PDMP) is from Biomol (reference SL- 
210). Reagents, unless otherwise specified, were from Sigma 
2.2. Oocyte treatments 
Isolated oocytes were prepared as described in ref. [12]. Germinal 
vesicle breakdown (GVBD) was ascertained by the absence of the 
germinal vesicle determined by oocyte dissection after fixation in 10% 
trichloroacetic acid. For some experiments, prophase oocytes were 
pretreated for 1 h in the presence of 100 fig/ml cycloheximide. or 1 mM 
3-isobutyl-I-methylxanthine (IBMX) and 0. I &ml cholera toxin. For 
kinetic analysis throughout post-GVBD maturation, prophase oocytes 
from a single female were treated with progesterone or PDMP. Oocytes 
just undergoing GVBD (first pigment rearrangement) were collected 
within a window of 5 min and these ‘synchronized’ oocytes were pooled. 
At regular intervals, oocytes were removed from the pooled oocytes and 
analyzed for histone Hl kinase assay. 
2.3. Extract preparation 
3 oocytes were washed in 1 ml MPF extraction buffer (EB: 80 mM 
/&glycerophosphate pH 7.3, 20 mM EGTA, 15 mM MgCl,, 1 mM 
dithiothreitol, and protease inhibitors: 2 mM phenylmethanesulfon- 
yifluoride, 25 ,@ml leupeptin, 25 pg/ml aprotinin, 10 &ml pepstatin, 
0.1 mg/ml soybean trypsin inhibitor and 1 mM benzamidine), homoge- 
nized in 50 ,~l EB at 4°C and centrifuged at 100,000 rpm at 4°C for 
10 min in a TL.100 Beckman centrifuge (TLA-100 rotor). The superna- 
tant was collected for p13 binding and histone-Hl kinase assays as 
described in [13]. For Western blot analysis, 15 oocytes were homoge- 
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nized in 40 ~1 of EB, centrifuged as previously described, and 15 ~1 of 
Laemmli buffer [14] was added to the supernatant. Proteins were elec- 
trophoresed and transferred to nitrocellulose filters (Schleicher and 
Schull) as described in ref. [13]. The anti-phosphotyrosine antibody is 
described in ref. [13] and the anti-MAP kinase antibody provided by 
Dr. J. Pouyssegur recognizes Xenopus oocyte p42 MAP kinase [15]. 
Anti-phosphotyrosine and anti-MAP kinase antibodies were revealed 
by autoradiography after [“‘I]protein-A incubation (DuPont NEN). 
2.4. Immunocytochemical procedures 
Oocytes were fixed in 1% acetic acid in 95” ethanol. Microtubular 
structures were revealed on cryostat serial sections (10 pm) by im- 
munofluorescence with an anti-Xenopus tubulin antibody [16] and a 
FITC-labelled anti-guinea pig IgG (Biosys B13 105). 
3. Results 
3.1. Exogenous ceramide does not promote GVBD in oocytes 
from unstimulated females 
It has been recently reported that oocyte external treatment 
in the presence of Staphylococcus aureus SMase induces meiotic 
maturation of Xenopus oocytes [5,6,8]. We confirmed and ex- 
tended these results with two SMases, extracted from Staphylo- 
coccus aureus and Streptomyces (see further). These results 
suggest that an accumulation of ceramide could in vivo pro- 
mote MPF activation and meiotic maturation. However, in 
contrast with the results of Strum et al. [8], incubation or micro- 
injection of oocytes with C2- or C8-ceramide, cell permeable 
short chain ceramide, failed to induce GVBD at all tested con- 
centrations (20 to 500 PM). The lack of effect of ceramide led 
us to test other metabolites known to act on sphingolipid me- 
tabolism. Fumonisin b,, a natural inhibitor of ceramide syn- 
thase [17,18] (Fig. l), neither induces maturation nor inhibits 
progesterone-induced maturation up to 50 ,uM, indicating that 
the biosynthetic pathway of ceramide synthesis is not critical 
for release of the prophase block. The possibility that metabo- 
lism between sphingolipids and glycosphingolipids (Fig. l), 
which have been characterized in Xenopus oocyte membranes 
[19], is involved in MPF activation was then investigated. 
3.2. PDMe an inhibitor of glucosylceramide synthase, induces 
GVBD in vivo 
DL-Threo- 1 -phenyl-2-decanoylamino-3-morpholino- 1 -pro- 
panol (PDMP) is an inhibitor of glucosylceramide synthase 
[l l] (Fig. 1). When applied to cultured cells, PDMP carries a 
time- dependent depletion of glycosphingolipids and a second- 
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Fig. 1, Metabolic pathway of ceramide. This simplified scheme illus- 
trates the role of ceramide in sphingolipid biosynthesis and catabolism, 
as well as the action level of the inhibitors used in this study. 
A. 
GVBD (w) 
100 
25 
0 
0 3.5 4 4.5 5 5.5 6 6.5 7 time (h) 
B. 
cpm in Hl 
20000 1 + -.- pg PDMP 
10000 
5000 
I+ 
‘q-h 
t time 
Fig. 2. PDMP induces GVBD in vivo. (A) Time course analysis of 
GVBD. (m-m): at time 0, prophase oocytes were incubated in the 
presence of 1 PM progesterone; (O-U): at time 0, prophase oocytes 
were incubated in the presence of 150 PM PDMP; (O-O): prophase 
oocytes were pretreated for 2 h in the presence of 100 pg/rnl cyclo- 
heximide before 150 PM PDMP addition at time 0; (+o): prophase 
oocytes were pretreated for 2 h in the presence of 1 mM IBMX and 0.1 
pg/ml cholera toxin before 150 PM PDMP addition at time 0. (B) 
PDMP induces in vivo ~34~‘~ kinase activation. At time 0 (arrow), 
oocytes were incubated in the presence of either 150 PM PDMP 
(er) or 1 PM progesterone (&a). Hl kinase activity of p34dcz was 
estimated at various times after GVBD. 
ary accumulation of sphingolipids [4,11]. PDMP is therefore an 
useful molecular tool to investigate the role of sphingolipids in 
regulation of specific cellular functions, including cell cycle 
[4,20]. Full-grown Xenopus oocytes were incubated in the pres- 
ence of 10 to 300pM PDMP. In at least 6 different females, 50% 
germinal vesicle breakdown (GVBD) was obtained with PDMP 
concentrations ranging from 50 to 150 PM. The appearance of 
the maturation white spot was slightly delayed when compared 
to control progesterone-induced GVBD (Fig. 2A). As proges- 
terone-induced maturation, PDMP induced-maturation is in- 
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:ig. 3. Cytological analysis of oocytes treated with progesterone. 
i’DMP and Streptomyces SMase. (A,B) Prophase-blocked oocytes were 
reated with 1 PM progesterone and fixed 3 h after GVBD (300 x): (A) 
chase contrast; (B) Hoechst dye staining; (C,D) Prophase oocytes were 
reated with 150 PM PDMP and fixed 3 h after GVBD (1500 x): (C) 
anti-tubulin antibody staining; (D) Hoechst dye staining; (E,F) Pro- 
chase oocytes were treated with 0.7 U/ml Streptomyces SMase and 
‘ixed 3 h after GVBD (1500 x): (E) Phase contrast; (F) Hoechst dye 
.taining. 
ribited either by cycloheximide or by an increase in the intracel- 
ular CAMP level (Fig. 2A). When PDMP-treated oocytes were 
cytologically analyzed 3 h after GVBD, a typical metaphase 
II-spindle was found anchored in the oocyte cortex, as after 
orogesterone induction (Fig. 3A-D). Similarly, oocytes ma- 
ured by external addition of Streptomyces SMase also exhibit 
1 typical metaphase II-spindle (Fig. 3E,F). 
1.3. PDMP induces in vivo ~34““’ kinase and MAP kinase 
activation 
The histone HI kinase activity of ~34~~“~ was measured at 
,different times after PDMP addition. The activation of the 
kinase as well as fluctuations of its activity after GVBD were 
indistinguishable from those induced by progesterone (Fig. 2B). 
fmmunoblots performed with an anti-phosphotyrosine anti- 
body show that ~34~” activation induced by PDMP or Strep- 
tomyces SMase correlates with tyrosine dephosphorylation of 
the protein at GVBD time (Fig. 4); interestingly, activation of 
MAP kinase, as judged by its retarded electrophoretic mobility, 
occurs at the same period (Fig. 4). As previously reported, 
tyrosine phosphorylation of MAP kinase was shown to corre- 
late with its mobility shift at GVBD time during progesterone- 
induced maturation [15]. Similarly, it was ascertained that 
PDMP and SMase lead to tyrosine phosphorylation of MAP 
kinase at GVBD (not shown). 
3.4. PDMP potentializes progesterone action 
Since PDMP is able to trigger a physiological meiotic matu- 
ration, we investigated the possibility that ceramide metabolism 
interferes in vivo in the signalling cascade initiated by the phys- 
iological inducer of maturation, progesterone. Oocytes were 
pretreated for 18 h by a subthreshold concentration of PDMP 
(10 PM), a dose which is not able to promote maturation, and 
then incubated in the presence of 1 PM progesterone (Fig. 5A). 
Time course of the progesterone-induced maturation process 
was accelerated (Fig. 5A). Conversely, pretreatment of oocytes 
with lo-” M progesterone, which is unable to elicit maturation, 
accelerates the action of 150pM PDMP (Fig. 5B), demonstrat- 
ing again that both signalling pathways of progesterone and 
sphingolipid metabolism in vivo are connected. 
4. Discussion 
Xenopus oocytes undergo normal meiotic maturation when 
treated with an inhibitor of glucosylceramide synthase. All cri- 
teria of PDMP-induced maturation which were analyzed 
(GVBD, p3pdc2 and MAP kinase activation, formation of a 
metaphase II spindle) were found to be comparable to proges- 
terone-induced maturation. Glucosylceramide synthase cata- 
lyzes the first step in the ganglioside biosynthetic pathway (Fig. 
1); as other ganglioside glucosyltransferases, this enzyme is 
associated with the ER/Golgi membranes in Xenopus oocytes 
[19]. Therefore, the main effect of its inhibition by PDMP in 
whole oocyte should be an increase in the level of ceramide and 
sphingomyelin in the inner leaflet of membrane vesicles traf- 
ficking from the ER through the Golgi apparatus to the plasma 
membrane. Since fumonisine bl, that inhibits ceramide synthe- 
sis [17,18] (Fig. l), does not influence PDMP or progesterone- 
induced maturation, it may be assumed that PDMP modifies 
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Fig. 4. PDMP and Streptomyces SMase induce activation of ~34’~” 
kinase and MAP kinase at GVBD time. Prophase oocytes were incu- 
bated in the presence of either 1 PM progesterone (lanes 2-3), or 0.7 
U/ml Streptomyces SMase (lanes 4-5) or 150 PM PDMP (lanes 67). 
Oocytes were analyzed at two different times: 2 h after various treat- 
ments (lanes 2, 4, 6) and at GVBD time (lanes 3, 5, 7). Lane 1, control 
not treated prophase oocytes. Upper line: Hl kinase activity (autoradi- 
ograph); middle line: Western blot with an anti-MAP kinase; lower line: 
tyrosine phosphorylation level of ~34““~ revealed with an anti- 
phosphotyrosine antibody. 
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Fig. 5. Reciprocal facilitation of PDMP and progesterone action on 
meiotic maturation. GVBD was scored at various times after different 
treatments of prophase oocytes. (A) Prophase oocytes pretreated with 
10 PM PDMP for 18 h and then incubated with 1 PM progesterone 
(o-o); prophase oocytes treated with 1 FM progesterone (04); pro- 
ohase oocvtes treated with 10 uM PDMP (O--O). (B) Prouhase oocytes 
‘pretreated with lOmE M proge’sterone for <S h and‘&en incubated with 
150 PM PDMP (o-o); prophase oocytes treated with 150 PM PDMP 
(u); prophase oocytes treated with lOma M progesterone (O-O). 
the interconversion between glycospingolipids, ceramide and 
sphingomyelin. 
Our unexpected findings show that the metabolism of sphin- 
golipids needs to be highly regulated in the prophase-blocked 
oocyte; they furthermore suggest the intriguing possibility that 
progesterone acts at the level of the membrane of the ERlGolgi 
vesicles. This hypothesis is reinforced by the recent finding that 
brefeldin A, that inhibits protein traffic in Xenopus oocytes, 
promotes meiotic maturation [21]. How does a local increase 
in the concentration of ceramide and sphingomyelin and the 
concomitant decrease of glycosphingolipids induce ~34~~~~ acti- 
vation? p34 cdc2 is activated in vivo by tyrosine dephosphoryla- 
tion, that is catalyzed by the cdc25 phosphatase [22]. Cdc25 is 
activated by phosphorylation by a not yet identified kinase, 
although it has been hypothetized that MPF itself and raf 
kinase could participate in ovo to this activating phosphoryla- 
tion [23,24]. Protein phosphatase 2A, that is in vitro stimulated 
by ceramide [25,26], negatively regulates directly or indirectly 
this step [27-301. The molecular mechanisms linking progester- 
one action and cdc25 and ~34”~“’ activation remain poorly 
understood. Among numerous possibilities, two non exclusive 
attractive hypotheses could now be envisaged: (1) A local mod- 
ification in the sphingolipid composition of membrane vesicles 
changes their targeting towards the plasma membrane or other 
intracellular membrane compartments. A major consequence 
of these modifications could be that a key protein implicated 
in ~34~~~’ activation and interacting with sphingolipids changes 
its spatial localization, leading to its accessibility to the activa- 
tion pathway of MPF. (2) A local release of ceramide from the 
vesicles could activate a key cytosolic enzyme involved up- 
stream of the pathway leading to MPF activation. 
The recent investigation of Strum et al. [8] favors this hypoth- 
esis, since they showed that in oocytes from Xenopus females 
primed with PMSG, ceramide microinjection induces matura- 
tion and that progesterone increases ceramide levels. These 
interesting results are, however, intriguing when basal and stim- 
ulated concentrations of ceramide are compared. As reported 
in [8], ceramide levels increase continuously during the matura- 
tion process, from 0.2-0.4 mM to reach 0.7 mM at the end of 
maturation. It is difficult to envisage that such high amounts 
can regulate enzymes that are known to be regulated by cer- 
amide in the micromolar range [25,26,31]. Strum et al. [S] fur- 
ther reported that microinjection of 40 pmol (40 PM in the 
oocyte) of C2 or C6 ceramide induces a very slow maturation 
process. We repeated these microinjection experiments in 
oocytes from unstimulated Xenopus females; whereas PDMP 
and two different SMases induce a normal maturation in these 
oocytes, microinjection as well as external incubation with C2 
or C6 ceramide were totally unefficient to promote entry into 
meiosis under our experimental conditions. It has to be noticed 
that in Xenopus oocytes from stimulated females, GVBD in 
response to progesterone occurs much earlier than in oocytes 
from unstimulated females. Thus, oocytes from stimulated fe- 
males could be downstream in the sequence of events leading 
to GVBD [32]. Therefore, dependent on the actual physiologi- 
cal stage reached by the oocytes, ceramide could have different 
or opposite effects. Whatever the explanation of the contradic- 
tion between our results and data published in ref. [8], to further 
clarify a possible role of ceramide as second messenger, it would 
be important to understand the physiological meaning of the 
basal and stimulated levels of ceramide in whole oocytes. 
In conclusion, both induction of maturation following sphin- 
gomyelin hydrolysis by SMase ([8]; these results) as well as by 
inhibiting glucosylceramide synthase by PDMP and the poten- 
tializing effect of PDMP on progesterone action indicate that 
sphingolipid metabolism is an important regulating process in 
the physiology of the oocyte. In the future, it will be important 
to determine whether ceramide acts on the sorting of an essen- 
tial protein at the level of the Golgi apparatus or as a second 
messenger. 
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